Shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) hit a new 52-week low during trading on Tuesday . The stock traded as low as $64.19 and last traded at $64.29, with a volume of 2264328 shares changing hands. The stock had previously closed at $65.68. Analyst Upgrades and Downgrades Several brokerages recently commented […]
Linscomb & Williams Inc. cut its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,427 shares of the biopharmaceutical company’s stock after selling 265 shares during the quarter. Linscomb & […]
Ontario Teachers Pension Plan Board trimmed its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 38.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 56,446 shares of the biopharmaceutical company’s stock after selling 34,741 shares […]
Simplicity Wealth LLC acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 21,827 shares of the biopharmaceutical company’s stock, valued at approximately $1,599,000. Several other hedge funds also recently added to or […]
Strait & Sound Wealth Management LLC lowered its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,240 shares of the biopharmaceutical company’s stock after selling 169 shares during the period. Strait & Sound Wealth […]